Abstract
Introduction
The implantation of biomaterials into soft tissue leads to the development of foreign body response, a non-specific inflammatory condition that is characterized by the presence of fibrotic tissue. Epithelial–mesenchymal transition (EMT) is a key event in development, fibrosis, and oncogenesis. Emerging data support a role for both a mechanical signal and a biochemical signal in EMT. We hypothesized that transient receptor potential vanilloid 4 (TRPV4), a mechanosensitive channel, is a mediator of EMT.
Methods
Normal human primary epidermal keratinocytes (NHEKs) were seeded on collagen-coated plastic plates or varied stiffness polyacrylamide gels in the presence or absence of TGFβ1. Immunofluorescence, immunoblot, and polymerase chain reaction analysis were performed to determine expression level of EMT markers and signaling proteins. Knock-down of TRPV4 function was achieved by siRNA transfection or by GSK2193874 treatment.
Results
We found that knock-down of TRPV4 blocked both matrix stiffness- and TGFβ1-induced EMT in NHEKs. In a murine skin fibrosis model, TRPV4 deletion resulted in decreased expression of the mesenchymal marker, α-SMA, and increased expression of epithelial marker, E-cadherin. Mechanistically, our data showed that: (i) TRPV4 was essential for the nuclear translocation of TAZ in response to matrix stiffness and TGFβ1; (ii) Antagonism of TRPV4 inhibited both matrix stiffness-induced and TGFβ1-induced expression of TAZ proteins; and (iii) TRPV4 antagonism suppressed both matrix stiffness-induced and TGFβ1-induced activation of Smad2/3, but not of AKT.
Conclusions
These data identify a novel role for TRPV4-TAZ mechanotransduction signaling axis in regulating EMT in NHEKs in response to both matrix stiffness and TGFβ1.
Similar content being viewed by others
References
Adapala, R. K., R. J. Thoppil, D. J. Luther, et al. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J. Mol. Cell. Cardiol. 54:45–52, 2013.
Aragona, M., T. Panciera, A. Manfrin, et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154:1047–1059, 2013.
Azimi, I., H. Beilby, F. M. Davis, et al. Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial–mesenchymal transition in breast cancer cells. Mol. Oncol. 10:166–178, 2016.
Bakin, A. V., A. K. Tomlinson, N. A. Bhowmick, et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:36803–36810, 2000.
Barker, T. H., M. M. Dysart, A. C. Brown, et al. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition. Res. Rep. Health Eff. Inst. 182:3–41, 2014.
Berridge, M. J., M. D. Bootman, and H. L. Roderick. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4:517–529, 2003.
Bordeleau, F., B. N. Mason, E. M. Lollis, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc. Natl. Acad. Sci. U.S.A. 114:492–497, 2017.
Brown, A. C., V. F. Fiore, T. A. Sulchek, et al. Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions. J. Pathol. 229:25–35, 2013.
Chaudhuri, O., S. T. Koshy, C. Branco da Cunha, et al. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat. Mater. 13:970–978, 2014.
Chen, Y., Q. Fang, Z. Wang, et al. Transient receptor potential vanilloid 4 ion channel functions as a pruriceptor in epidermal keratinocytes to evoke histaminergic itch. J. Biol. Chem. 291:10252–10262, 2016.
Chen, X. F., H. J. Zhang, H. B. Wang, et al. Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3 K/Akt and MEK/Erk1/2 signaling pathways. Mol. Biol. Rep. 39:3549–3556, 2012.
Choi, J., S. Y. Park, and C. K. Joo. Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 48:2708–2718, 2007.
Davis, F. M., I. Azimi, R. A. Faville, et al. Induction of epithelial–mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene 33:2307–2316, 2014.
Degryse, A. L., H. Tanjore, X. C. Xu, et al. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment. Am. J. Physiol. Lung Cell. Mol. Physiol. 300:L887–897, 2011.
Discher, D. E., P. Janmey, and Y. L. Wang. Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139–1143, 2005.
Dupont, S., L. Morsut, M. Aragona, et al. Role of YAP/TAZ in mechanotransduction. Nature 474:179–183, 2011.
Everaerts, W., B. Nilius, and G. Owsianik. The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog. Biophys. Mol. Biol. 103:2–17, 2010.
Everaerts, W., X. Zhen, D. Ghosh, et al. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc. Natl. Acad. Sci. U.S.A. 107:19084–19089, 2010.
Fukawa, T., H. Kajiya, S. Ozeki, et al. Reactive oxygen species stimulates epithelial mesenchymal transition in normal human epidermal keratinocytes via TGF-beta secretion. Exp. Cell Res. 318:1926–1932, 2012.
Garcia-Elias, A., S. Mrkonjić, C. Jung, et al. The TRPV4 channel. Handb. Exp. Pharmacol. 222:293–319, 2014.
Georges, P. C., J. J. Hui, Z. Gombos, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G1147–1154, 2007.
Goswami, R., J. Cohen, S. Sharma, et al. TRPV4 ion channel is associated with scleroderma. J. Invest. Dermatol. 137:962–965, 2017.
Guan, R., X. Wang, X. Zhao, et al. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial–mesenchymal transition and fibroblast activation. Sci. Rep. 6:35696, 2016.
Hackett, T. L., S. M. Warner, D. Stefanowicz, et al. Induction of epithelial–mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am. J. Respir. Crit. Care Med. 180:122–133, 2009.
Hdud, I. M., A. Mobasheri, and P. T. Loughna. Effect of osmotic stress on the expression of TRPV4 and BKCa channels and possible interaction with ERK1/2 and p38 in cultured equine chondrocytes. Am. J. Physiol. Cell Physiol. 306:C1050–1057, 2014.
Huang, C., S. Akaishi, and R. Ogawa. Mechanosignaling pathways in cutaneous scarring. Arch. Dermatol. Res. 304:589–597, 2012.
Humphrey, J. D., E. R. Dufresne, and M. A. Schwartz. Mechanotransduction and extracellular matrix homeostasis. Nat. Rev. Mol. Cell Biol. 15:802–812, 2014.
Iamshanova, O., A. FiorioPla, and N. Prevarskaya. Molecular mechanisms of tumour invasion: regulation by calcium signals. J. Physiol. 595:3063–3075, 2017.
Janssen, L. J., S. Mukherjee, and K. Ask. Calcium homeostasis and ionic mechanisms in pulmonary fibroblasts. Am. J. Respir. Cell Mol. Biol. 53:135–148, 2015.
Kida, N., T. Sokabe, M. Kashio, et al. Importance of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier function in human skin keratinocytes. Pflugers Arch. 463:715–725, 2012.
Kolosova, I., D. Nethery, and J. A. Kern. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial–mesenchymal transition of pulmonary epithelial cells. J. Cell. Physiol. 226:1248–1254, 2011.
Krainock, M., O. Toubat, S. Danopoulos, et al. Epicardial epithelial-to-mesenchymal transition in heart development and disease. J. Clin. Med. 5(2):7, 2016.
Kumar, S. Cellular mechanotransduction: stiffness does matter. Nat. Mater. 13:918–920, 2014.
Lai, W., L. Liu, Y. Zeng, et al. KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer. Med. Oncol. 30:566, 2013.
Lamouille, S., J. Xu, and R. Derynck. Molecular mechanisms of epithelial–mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15:178–196, 2014.
Lei, Q. Y., H. Zhang, B. Zhao, et al. TAZ promotes cell proliferation and epithelial–mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28:2426–2436, 2008.
Leight, J. L., M. A. Wozniak, S. Chen, et al. Matrix rigidity regulates a switch between TGF-β1-induced apoptosis and epithelial–mesenchymal transition. Mol. Biol. Cell 23:781–791, 2012.
Li, Z., Y. Wang, Y. Zhu, et al. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Mol. Oncol. 9:1091–1105, 2015.
Liu, F., D. Lagares, K. M. Choi, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 308:L344–L357, 2015.
Mai, X., J. Shang, S. Liang, et al. Blockade of Orai1 store-operated calcium entry protects against renal fibrosis. J. Am. Soc. Nephrol. 27:3063–3078, 2016.
Masszi, A., L. Fan, L. Rosivall, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am. J. Pathol. 165:1955–1967, 2004.
Mauviel, A., F. Nallet-Staub, and X. Varelas. Integrating developmental signals: a Hippo in the (path)way. Oncogene 31:1743–1756, 2012.
Mendez, M. G., and P. A. Janmey. Transcription factor regulation by mechanical stress. Int. J. Biochem. Cell Biol. 44:728–732, 2012.
Miranda, M. Z., J. F. Bialik, P. Speight, et al. TGF-β1 regulates the expression and transcriptional activity of TAZ via a Smad3-independent, myocardin-related transcription factor-mediated mechanism. J. Biol. Chem. 2017. https://doi.org/10.1074/jbc.M117.780502.
Moore, C., F. Cevikbas, H. A. Pasolli, et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc. Natl. Acad. Sci. U.S.A. 110:E3225–3234, 2013.
Nasrollahi, S., and A. Pathak. Topographic confinement of epithelial clusters induces epithelial-to-mesenchymal transition in compliant matrices. Sci. Rep. 6:18831, 2016.
Nawshad, A., D. Lagamba, A. Polad, et al. Transforming growth factor-beta signaling during epithelial–mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179:11–23, 2005.
Nayak, P. S., Y. Wang, T. Najrana, et al. Mechanotransduction via TRPV4 regulates inflammation and differentiation in fetal mouse distal lung epithelial cells. Respir. Res. 16:60, 2015.
Nieves-Cintrón, M., G. C. Amberg, M. F. Navedo, et al. The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc. Natl. Acad. Sci. U.S.A. 105:15623–15628, 2008.
Nikitorowicz-Buniak, J., C. P. Denton, D. Abraham, et al. Partially evoked epithelial-mesenchymal transition (EMT) is associated with increased TGFβ signaling within lesional scleroderma skin. PLoS ONE 10:e0134092, 2015.
Noguchi, S., A. Saito, Y. Mikami, et al. TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts. Sci. Rep. 7:42595, 2017.
Nowrin, K., S. S. Sohal, G. Peterson, et al. Epithelial–mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev. Respir. Med. 8:547–559, 2014.
O’Connor, J. W., P. N. Riley, S. M. Nalluri, et al. Matrix rigidity mediates TGFβ1-induced epithelial-myofibroblast transition by controlling cytoskeletal organization and MRTF-A localization. J. Cell. Physiol. 230:1829–1839, 2015.
O’Kane, D., M. V. Jackson, A. Kissenpfennig, et al. SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro. Exp. Dermatol. 23:497–503, 2014.
Paszek, M. J., N. Zahir, K. R. Johnson, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8:241–254, 2005.
Peinado, H., M. Quintanilla, and A. Cano. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 278:21113–21123, 2003.
Piersma, B., R. A. Bank, and M. Boersema. Signaling in fibrosis: TGF-β, WNT, and YAP/TAZ converge. Front. Med. (Lausanne) 2:59, 2015.
Plant, T. D., and R. Strotmann. TRPV4. Handb. Exp. Pharmacol. 179:189–205, 2007.
Polimeni, M., G. R. Gulino, E. Gazzano, et al. Multi-walled carbon nanotubes directly induce epithelial–mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway. Part. Fibre Toxicol. 13:27, 2016.
Rahaman, S. O., L. M. Grove, S. Paruchuri, et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J. Clin. Invest. 124:5225–5238, 2014.
Rice, A. J., E. Cortes, D. Lachowski, et al. Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis 6:e352, 2017.
Roderick, H. L., and S. J. Cook. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 8:361–375, 2008.
Saito, A., and T. Nagase. Hippo and TGF-β interplay in the lung field. Am. J. Physiol. Lung Cell. Mol. Physiol. 309:L756–L767, 2015.
Santana, A., B. Saxena, N. A. Noble, et al. Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 13:34–44, 1995.
Sharma, S., R. Goswami, M. Merth, et al. TRPV4 ion channel is a novel regulator of dermal myofibroblast differentiation. Am. J. Physiol. Cell Physiol. 312:C562–C572, 2017.
Sokabe, T., and M. Tominaga. The TRPV4 cation channel: a molecule linking skin temperature and barrier function. Commun Integr Biol 3:619–621, 2010.
Speight, P., H. Nakano, T. J. Kelley, et al. Differential topical susceptibility to TGFβ in intact and injured regions of the epithelium: key role in myofibroblast transition. Mol. Biol. Cell 24:3326–3336, 2013.
Stone, R. C., I. Pastar, N. Ojeh, et al. Epithelial–mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res. 365:495–506, 2016.
Sulk, M., S. Seeliger, J. Aubert, et al. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J. Invest. Dermatol. 132:1253–1262, 2012.
Suzuki, M., A. Mizuno, K. Kodaira, et al. Impaired pressure sensation in mice lacking TRPV4. J. Biol. Chem. 278:22664–22668, 2003.
Szeto, S. G., M. Narimatsu, M. Lu, et al. YAP/TAZ are mechanoregulators of TGF-β-Smad signaling and renal fibrogenesis. J. Am. Soc. Nephrol. 27:3117–3128, 2016.
Tanjore, H., X. C. Xu, V. V. Polosukhin, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 180:657–665, 2009.
Tennakoon, A. H., T. Izawa, M. Kuwamura, et al. Pathogenesis of type 2 epithelial to mesenchymal transition (EMT) in renal and hepatic fibrosis. J. Clin. Med. 5(1):4, 2015.
Thorneloe, K. S., M. Cheung, W. Bao, et al. An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci. Transl. Med. 4:159ra148, 2012.
Trimboli, A. J., K. Fukino, A. de Bruin, et al. Direct evidence for epithelial–mesenchymal transitions in breast cancer. Cancer Res. 68:937–945, 2008.
Tschumperlin, D. J. Fibroblasts and the ground they walk on. Physiology (Bethesda) 28:380–390, 2013.
Tschumperlin, D. J., F. Liu, and A. M. Tager. Biomechanical regulation of mesenchymal cell function. Curr. Opin. Rheumatol. 25:92–100, 2013.
Varelas, X., R. Sakuma, P. Samavarchi-Tehrani, et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 10:837–848, 2008.
Wang, Q., Z. Xu, Q. An, et al. TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells. Mol. Med. Rep. 11:982–988, 2015.
Wei, S. C., L. Fattet, J. H. Tsai, et al. Matrix stiffness drives epithelial–mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat. Cell Biol. 17:678–688, 2015.
Wen, L., C. Liang, E. Chen, et al. Regulation of multi-drug resistance in hepatocellular carcinoma cells is TRPC6/calcium dependent. Sci. Rep. 6:23269, 2016.
Wipff, P. J., D. B. Rifkin, J. J. Meister, et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179:1311–1323, 2007.
Xu, J., S. Lamouille, and R. Derynck. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156–172, 2009.
Yamamoto, T., S. Takagawa, I. Katayama, et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J. Invest. Dermatol. 112:456–462, 1999.
Yang, H. W., S. A. Lee, J. M. Shin, et al. Glucocorticoids ameliorate TGF-β1-mediated epithelial-to-mesenchymal transition of airway epithelium through MAPK and Snail/Slug signaling pathways. Sci. Rep. 7:3486, 2017.
Yang, N., C. D. Morrison, P. Liu, et al. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle 11:2922–2930, 2012.
Yeh, Y. C., W. C. Wei, Y. K. Wang, et al. Transforming growth factor-(beta)1 induces Smad3-dependent (beta)1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am. J. Pathol. 177:1743–1754, 2010.
Yeung, T., P. C. Georges, L. A. Flanagan, et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 60:24–34, 2005.
Zeisberg, M., and E. G. Neilson. Biomarkers for epithelial–mesenchymal transitions. J. Clin. Invest. 119:1429–1437, 2009.
Zhang, D. X., S. A. Mendoza, A. H. Bubolz, et al. Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo. Hypertension 53:532–538, 2009.
Zhao, X. H., C. Laschinger, P. Arora, et al. Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 120:1801–1809, 2007.
Zhou, C. F., D. C. Zhou, J. X. Zhang, et al. Bleomycin-induced epithelial–mesenchymal transition in sclerotic skin of mice: possible role of oxidative stress in the pathogenesis. Toxicol. Appl. Pharmacol. 277:250–258, 2014.
ACKNOWLEDGMENTS
Startup grant from University of Maryland, NIH (1R01EB024556-01), and NSF (CMMI-1662776) grants to Shaik O. Rahaman.
AUTHOR CONTRIBUTIONS
SS and SOR conceived the study, designed and performed the experiments, and wrote the manuscript. RG assisted with experiments and analysis of data, and maintained the animal colony. All authors reviewed the results and approved the final content of the manuscript.
Conflict of interest
Shweta Sharma, Rishov Goswami, and Shaik O. Rahaman declare that they have no conflicts of interest.
ETHICAL APPROVAL
The study protocol was approved by the University of Maryland Review Committee, and all experiments were performed in accordance with the IACUC guidelines.
INFORMED CONSENT
This article does not contain any studies with human participants performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor James L. McGrath oversaw the review of this article.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig.
1 TRPV4 antagonism suppresses Ca2+ influx and modulates expression of matrix stiffness and TGFβ1-induced ECAD and α-SMA. (A) FlexStation 3 recording of Calcium 6 dye-loaded NHEK monolayers assessing effects of TRPV4 selective antagonist, GSK219, on Ca2+ influx induced by calcium ionophore, A23 (2 μM) or TRPV4 selective agonist, GSK101 (20 nM). Bar graph is showing the quantified results (mean ± SEM). All experiments were performed 3 times in quadruplicate. **p < 0.01; 1-way ANOVA. (B and C) NHEKs were plated on collagen-coated (10 μg/mL) plastic plates and were incubated with or without GSK219 for 24 h. qRT-PCR analysis was performed to determine ECAD, GAPDH, and Vimentin mRNA levels using SYBR Green gene Expression Assay. Ct values were normalized to GAPDH levels. **p < 0.01; 1-way ANOVA. (D) NHEKs were plated on soft (1 kPa) or stiff (25 kPa) polyacrylamide hydrogels coated with collagen (10 μg/mL), and were incubated with or without TGFβ1 (5 ng/mL) for 96 h. For this experiment, we refreshed the media with GSK219 (5 nM) every 24 h. The data shown is one of the representative images from four different fields per condition to assess the capacity of TRPV4 inhibition (by GSK219) to inhibit matrix stiffness and TGFβ1-induced increases in the expression of ECAD and α-SMA. ECAD (red), α-SMA (green), and DAPI (blue) stains are shown. Scale bars: 10 µm. (E) Quantitation of results shown in D. Data are expressed as mean ± SEM of three independent experiments, n = 20 cells/condition. ns = non-significant; **p < 0.01, ***p < 0.001; 1-way ANOVA. hpf: high power field. (PDF 3096 kb)
Supplementary Fig.
2 TRPV4 inhibition by siRNA modulates expression of matrix stiffness and TGFβ1-induced ECAD and α-SMA. (A) NHEKs were plated on soft (1 kPa) or stiff (25 kPa) collagen-coated (10 μg/mL) polyacrylamide hydrogels, and were transfected with scrambled siRNA (Scr) or TRPV4 specific siRNA (si-TRPV4) for 96 h. ECAD (red), α-SMA (green), and DAPI (blue) stains are shown. Scale bars: 10 µm. (B) Quantitation of results shown in A. Data are expressed as mean ± SEM of three independent experiments, n = 20 cells/condition. ns = non-significant; *p < 0.05, **p < 0.01, ***p < 0.001; 1-way ANOVA. hpf: high power field. (PDF 6799 kb)
Rights and permissions
About this article
Cite this article
Sharma, S., Goswami, R. & Rahaman, S.O. The TRPV4-TAZ Mechanotransduction Signaling Axis in Matrix Stiffness- and TGFβ1-Induced Epithelial-Mesenchymal Transition. Cel. Mol. Bioeng. 12, 139–152 (2019). https://doi.org/10.1007/s12195-018-00565-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12195-018-00565-w